Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang, Peking university, China

Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Anmin Huang

Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.

🎓 Education & Work Experience

  • Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology

  • Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma

🏆 Achievements

  • Research Publications đź“š

    • Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering

    • Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis

    • Contributed to the study of tumor immune infiltration and immunotherapy response

  • Patents & Innovations 🧪

    • Holder of two utility model patents for laboratory equipment

    • Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy

    • Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method

🎖 Awards & Honors

  • Recognized for cutting-edge research in oncology and immunotherapy

  • Contributions to novel cancer treatment strategies and immune regulation

Publication Top Notes:

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites

 

Mrs. Yulia Desheva | Immunology Award | Best Researcher Award

Posted on by ScienceFather

Mrs. Yulia Desheva | Immunology Award | Best Researcher Award

Mrs. Yulia Desheva, Institute of Experimental Medicine, Russia

Yulia Desheva is a researcher affiliated with St. Petersburg State University, specializing in immunology and vaccine development. She has made significant contributions to the field, particularly in the study of immune responses to viral infections and the development of probiotic-based vaccines. With a Web of Science ResearcherID of I-1493-2013 and an ORCiD of 0000-0001-9794-3520, her research is well-documented, showcasing an impressive H-index of 55. Over her career, Yulia has published 37 papers, accumulating a total of 847 citations, highlighting her impact in scientific literature. Recent publications include work on SARS-CoV-2 vaccination strategies and influenza virus immunology, reflecting her commitment to advancing public health through innovative research.

Professional Profile:

ORCID

Summary of Suitability for the Best Researcher Award: Yulia Desheva

Yulia Desheva is an exemplary candidate for the Best Researcher Award due to her significant contributions to the field of immunology and vaccine development. Affiliated with St. Petersburg State University, her research has yielded an impressive publication record, including 37 total publications with an H-index of 55, reflecting her impactful contributions and recognition by peers.

🎓 Education

  • Ph.D. in Biological Sciences
    St. Petersburg State University
    Master’s Degree in Microbiology
    Bachelor’s Degree in Biology

🔬 Research Focus

Yulia Desheva specializes in the development of oral probiotic vaccines, immunogenic responses, and antibody analysis related to viral infections such as SARS-CoV-2 and influenza. Her innovative research is crucial for understanding immune responses and improving vaccine efficacy.

🏆 Achievements

  • Significant contributions to the fields of microbiology and immunology through published research.
  • Engaged in high-impact studies on vaccine development and immune response analysis.

🌟 Key Areas of Interest

  • Probiotic-based vaccines
  • Immune response mechanisms
  • Viral infections and vaccine development
  • Antibody analysis in infectious diseases

Publication top Notes:

Immune response and laboratory markers in the spectrum of severity of COVID-19

Exploring Immune Response and Lab Markers Across COVID-19 Severity Levels

Evaluation of Immune Response to Mucosal Immunization with an Oral Probiotic-Based Vaccine in Mice: Potential for Prime-Boost Immunization against SARS-CoV-2

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection